Journal
CURRENT ATHEROSCLEROSIS REPORTS
Volume 16, Issue 2, Pages -Publisher
CURRENT MEDICINE GROUP
DOI: 10.1007/s11883-013-0386-9
Keywords
atherosclerosis; cardiovascular disease; diabetes; hyperlipidemia; insulin resistance; matrix metalloproteinase; metabolics; microRNA; obesity; proteomics
Categories
Funding
- Lilly
- BMS
- Grants-in-Aid for Scientific Research [25460662] Funding Source: KAKEN
Ask authors/readers for more resources
MicroRNAs (miRNAs) are a class of post-transcriptional regulators that provide a mechanism of gene silencing by translational repression or degradation of the targeted gene. Gene expression regulation by miRNAs is involved in most if not all physiological and pathophysiological processes. Atherosclerosis is a major cardiovascular disease pathology regulated by miRNAs. Recent miRNA profiling studies have implicated the potential use of miRNAs as biomarkers in patients with atherosclerosis, as both diagnostic and prognostic indicators. This review will discuss the clinical and basic science research information that has been gleaned regarding miRNA roles in dyslipidemia, diabetes, obesity, and insulin resistance which are the major stimulators for the development of atherosclerosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available